RS54926B1 - Derivati sterola, metodi njihovog pripremanja, farmaceutske smeše koje ih sadrže, i njihova upotreba u lečenju multiplih glioblastoma - Google Patents
Derivati sterola, metodi njihovog pripremanja, farmaceutske smeše koje ih sadrže, i njihova upotreba u lečenju multiplih glioblastomaInfo
- Publication number
- RS54926B1 RS54926B1 RS20160499A RSP20160499A RS54926B1 RS 54926 B1 RS54926 B1 RS 54926B1 RS 20160499 A RS20160499 A RS 20160499A RS P20160499 A RSP20160499 A RS P20160499A RS 54926 B1 RS54926 B1 RS 54926B1
- Authority
- RS
- Serbia
- Prior art keywords
- group
- compound
- formula
- substituted
- unsubstituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
- C07J9/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12305518.8A EP2662382B1 (fr) | 2012-05-10 | 2012-05-10 | Dérivés de stérol, leur procédé de préparation, les compositions pharmaceutiques les contenant et leur utilisation pour le traitement du glioblastome multiple |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RS54926B1 true RS54926B1 (sr) | 2016-10-31 |
Family
ID=46149353
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RS20160499A RS54926B1 (sr) | 2012-05-10 | 2012-05-10 | Derivati sterola, metodi njihovog pripremanja, farmaceutske smeše koje ih sadrže, i njihova upotreba u lečenju multiplih glioblastoma |
| RS20180237A RS57065B1 (sr) | 2012-05-10 | 2013-05-07 | Derivati sterola i njihova upotreba za lečenje bolesti koje obuhvataju transformisane ćelije astrocite ili za lečenje malignih hemopatija |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RS20180237A RS57065B1 (sr) | 2012-05-10 | 2013-05-07 | Derivati sterola i njihova upotreba za lečenje bolesti koje obuhvataju transformisane ćelije astrocite ili za lečenje malignih hemopatija |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US10800806B2 (OSRAM) |
| EP (2) | EP2662382B1 (OSRAM) |
| JP (1) | JP6270823B2 (OSRAM) |
| KR (1) | KR102160316B1 (OSRAM) |
| CN (1) | CN104302655B (OSRAM) |
| BR (1) | BR112014026948B1 (OSRAM) |
| CA (1) | CA2871714C (OSRAM) |
| CY (2) | CY1117723T1 (OSRAM) |
| DK (2) | DK2662382T3 (OSRAM) |
| ES (2) | ES2580331T3 (OSRAM) |
| HR (2) | HRP20180345T1 (OSRAM) |
| HU (2) | HUE029243T2 (OSRAM) |
| IN (1) | IN2014DN09437A (OSRAM) |
| LT (1) | LT2847204T (OSRAM) |
| ME (1) | ME02436B (OSRAM) |
| PL (2) | PL2662382T3 (OSRAM) |
| PT (2) | PT2662382T (OSRAM) |
| RS (2) | RS54926B1 (OSRAM) |
| RU (1) | RU2627710C2 (OSRAM) |
| SI (2) | SI2662382T1 (OSRAM) |
| SM (2) | SMT201800147T1 (OSRAM) |
| TR (1) | TR201802700T4 (OSRAM) |
| WO (1) | WO2013168096A1 (OSRAM) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR3013048A1 (fr) * | 2013-11-12 | 2015-05-15 | Beta Innov | Derive de sterol, son procede de preparation, composition pharmaceutique le contenant et son utilisation pour le traitement du glioblastome multiforme |
| EP3593789A1 (fr) * | 2018-07-11 | 2020-01-15 | Beta Innov | Composition contenant un dérivé de 7beta-hydroxycholestérol et un véhicule lipidique, et son utilisation dans le traitement de pathologies néoplasiques |
| WO2022245122A1 (ko) * | 2021-05-18 | 2022-11-24 | 연세대학교 산학협력단 | 암의 예방, 개선 또는 치료용 조성물 |
| KR102689231B1 (ko) * | 2021-05-18 | 2024-07-30 | 연세대학교 산학협력단 | 암의 예방, 개선 또는 치료용 조성물 |
| WO2024030660A2 (en) * | 2022-08-04 | 2024-02-08 | University Of Massachusetts | Cholesterol-modified hyaluronic acids |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9602100D0 (sv) * | 1996-05-30 | 1996-05-30 | Magnus Axelson | New pharmaceuticals |
| BR0314700A (pt) * | 2002-09-25 | 2005-07-26 | Forbes Medi Tech Inc | Derivados que compreendem esteróis e/ou estanóis e classes especìficas de agentes antiinflamatórios e seu uso no tratamento ou prevenção de doença cardiovascular |
-
2012
- 2012-05-10 DK DK12305518.8T patent/DK2662382T3/en active
- 2012-05-10 HU HUE12305518A patent/HUE029243T2/en unknown
- 2012-05-10 RS RS20160499A patent/RS54926B1/sr unknown
- 2012-05-10 PT PT123055188T patent/PT2662382T/pt unknown
- 2012-05-10 PL PL12305518.8T patent/PL2662382T3/pl unknown
- 2012-05-10 ES ES12305518.8T patent/ES2580331T3/es active Active
- 2012-05-10 ME MEP-2016-134A patent/ME02436B/me unknown
- 2012-05-10 EP EP12305518.8A patent/EP2662382B1/fr active Active
- 2012-05-10 SI SI201230585A patent/SI2662382T1/sl unknown
-
2013
- 2013-05-07 LT LTEP13729470.8T patent/LT2847204T/lt unknown
- 2013-05-07 HU HUE13729470A patent/HUE037004T2/hu unknown
- 2013-05-07 CA CA2871714A patent/CA2871714C/en active Active
- 2013-05-07 DK DK13729470.8T patent/DK2847204T3/en active
- 2013-05-07 WO PCT/IB2013/053669 patent/WO2013168096A1/en not_active Ceased
- 2013-05-07 SI SI201330962T patent/SI2847204T1/en unknown
- 2013-05-07 RS RS20180237A patent/RS57065B1/sr unknown
- 2013-05-07 CN CN201380023824.4A patent/CN104302655B/zh active Active
- 2013-05-07 US US14/399,336 patent/US10800806B2/en active Active
- 2013-05-07 PT PT137294708T patent/PT2847204T/pt unknown
- 2013-05-07 IN IN9437DEN2014 patent/IN2014DN09437A/en unknown
- 2013-05-07 EP EP13729470.8A patent/EP2847204B1/en active Active
- 2013-05-07 TR TR2018/02700T patent/TR201802700T4/tr unknown
- 2013-05-07 ES ES13729470.8T patent/ES2662123T3/es active Active
- 2013-05-07 KR KR1020147034290A patent/KR102160316B1/ko active Active
- 2013-05-07 BR BR112014026948-3A patent/BR112014026948B1/pt active IP Right Grant
- 2013-05-07 PL PL13729470T patent/PL2847204T3/pl unknown
- 2013-05-07 HR HRP20180345TT patent/HRP20180345T1/hr unknown
- 2013-05-07 JP JP2015510925A patent/JP6270823B2/ja active Active
- 2013-05-07 SM SM20180147T patent/SMT201800147T1/it unknown
- 2013-05-07 RU RU2014149705A patent/RU2627710C2/ru active
-
2016
- 2016-06-07 HR HRP20160624TT patent/HRP20160624T1/hr unknown
- 2016-07-05 CY CY20161100621T patent/CY1117723T1/el unknown
- 2016-07-05 SM SM201600215T patent/SMT201600215B/it unknown
-
2018
- 2018-03-13 CY CY20181100306T patent/CY1120395T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Tsepaeva et al. | Design, synthesis, and cancer cell growth inhibitory activity of triphenylphosphonium derivatives of the triterpenoid betulin | |
| Legigan et al. | Synthesis and biological evaluations of a monomethylauristatin E glucuronide prodrug for selective cancer chemotherapy | |
| RS54926B1 (sr) | Derivati sterola, metodi njihovog pripremanja, farmaceutske smeše koje ih sadrže, i njihova upotreba u lečenju multiplih glioblastoma | |
| CN105924492B (zh) | 靶向线粒体的抗肿瘤五环三萜衍生物及其制备方法与应用 | |
| Kwak et al. | Blood-brain barrier-permeable fluorone-labeled dieckols acting as neuronal ER stress signaling inhibitors | |
| Sun et al. | A novel oral prodrug-targeting transporter MCT 1: 5-fluorouracil-dicarboxylate monoester conjugates | |
| JP2016536360A (ja) | パントテン酸キナーゼ関連神経変性症（ｐｋａｎ）の治療のための安定なパンテテイン誘導体およびそのような化合物の合成方法 | |
| CN110229168A (zh) | 11,20-二羰基济源冬凌草甲素及其l-氨基酸-14-酯三氟乙酸盐 | |
| Kang et al. | Discovery of a novel water-soluble, rapid-release triptolide prodrug with improved drug-like properties and high efficacy in human acute myeloid leukemia | |
| Zhang et al. | Incorporation of amino moiety to alepterolic acid improve activity against cancer cell lines: Synthesis and biological evaluation | |
| Liu et al. | Leonurine-cysteine analog conjugates as a new class of multifunctional anti-myocardial ischemia agent | |
| Baltina Jr et al. | Synthesis and anti-HIV-1 activity of new conjugates of 18 β-and 18 α-glycyrrhizic acids with aspartic acid esters | |
| Liu et al. | Novel octapeptide-DTX prodrugs targeting MMP-7 as effective agents for the treatment of colorectal cancer with lower systemic toxicity | |
| Huang et al. | Synthesis, characterization, and biological studies of diosgenyl analogs | |
| JP2002504509A (ja) | タンパク質ファルネシル転移酵素阻害剤 | |
| More et al. | Glycosylation enhances the anti-migratory activities of isomalyngamide A analogs | |
| Yang et al. | Click chemistry approach to characterize curcumin-protein interactions in vitro and in vivo | |
| CN104151388B (zh) | 抗肿瘤药物lqc-y的制备及其应用 | |
| CN107188923A (zh) | 乙烷‑1,2‑双救必应酸酯医药新用途 | |
| Feng et al. | Discovery of novel peptide–dehydroepiandrosterone hybrids inducing endoplasmic reticulum stress with effective in vitro and in vivo anti-melanoma activities | |
| RU2440998C1 (ru) | Производные 4-арилкумаринов и противоопухолевое лекарственное средство на их основе | |
| HK1191654B (en) | Sterol derivatives, method for preparing same, pharmaceutical compositions containing same and use thereof for the treatment of multiple glioblastomas | |
| FR3013048A1 (fr) | Derive de sterol, son procede de preparation, composition pharmaceutique le contenant et son utilisation pour le traitement du glioblastome multiforme | |
| CN104293859A (zh) | 一种半乳糖配体分子的酶促合成方法 |